LymphedemaV1, PascalFrancis, Corpus, bibRecord, 000542

Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study

Identifieur interne : 000542 ( PascalFrancis/Corpus ); précédent : 000541; suivant : 000543

Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study

Auteurs : Mourad Mokni ; Alain Dupuy ; Mohamed Denguezli ; Raouf Dhaoui ; Samir Bouassida ; Montacer Amri ; Sami Fenniche ; Faten Zeglaoui ; Nejib Doss ; Rafiaa Nouira ; Amel Ben Osman-Dhahri ; Jamel Zili ; Insaf Mokhtar ; MOHAMED RIDHA KAMOUN ; Abdelmajid Zahaf ; Olivier Chosidow

Source :

Dermatology : (Basel) [ 1018-8665 ] ; 2006.

RBID : Pascal:06-0128490

Descripteurs français

Pascal (Inist)
- Cellulite, Lymphoedème, Intertrigo, Facteur risque, Erysipèle, Jambe, Tunisie, Etude multicentrique, Etude cas témoin, Epidémiologie, Dermatologie, Homme, Médecine tropicale.

English descriptors

KwdEn :
- Case control study, Cellulitis, Dermatology, Epidemiology, Erysipelas, Human, Intertrigo, Leg, Lymphedema, Multicenter study, Risk factor, Tropical medicine, Tunisia.

Abstract

Background: Risk factors for erysipelas (cellulitis) were rarely evaluated in controlled studies. Regional variations of these risk factors have never be assessed. Objective: To assess risk factors for erysipelas of the leg in Tunisia. Subjects and Methods: Case-control study in seven hospital centers in Tunisia. Cases were 114 consecutive patients with erysipelas of the leg [sudden onset (<24 h) of a well-demarcated dermo-hypodermatitis with fever or chills]. Two controls were matched to each case for age, sex, and hospital (n = 208). Main outcome measures are local and general suspected risk factors for erysipelas of the leg. Results: In multivariate analysis, disruption of the cutaneous barrier (i.e. traumatic wound, toe-web intertrigo, excoriated leg dermatosis or plantar squamous lesions) and leg edema were independently associated with erysipelas of the leg, with respective odds ratios of 13.6 (95% confidence interval: 6.0-31) and 7.0 (1.3-38). No association was observed with diabetes, alcoholism, or smoking. Conclusions: We confirmed the major role of local risk factors and the minor role of general risk factors for erysipelas of the leg, in a setting different than the one previously studied. Detecting and treating toe-web intertrigo and traumatic wounds should be considered in the prevention of erysipelas of the leg.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 1018-8665`
A03		`1`		`@0 Dermatology : (Basel)`
A05				`@2 212`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study`
A11	`01`	`1`		`@1 MOKNI (Mourad)`
A11	`02`	`1`		`@1 DUPUY (Alain)`
A11	`03`	`1`		`@1 DENGUEZLI (Mohamed)`
A11	`04`	`1`		`@1 DHAOUI (Raouf)`
A11	`05`	`1`		`@1 BOUASSIDA (Samir)`
A11	`06`	`1`		`@1 AMRI (Montacer)`
A11	`07`	`1`		`@1 FENNICHE (Sami)`
A11	`08`	`1`		`@1 ZEGLAOUI (Faten)`
A11	`09`	`1`		`@1 DOSS (Nejib)`
A11	`10`	`1`		`@1 NOUIRA (Rafiaa)`
A11	`11`	`1`		`@1 BEN OSMAN-DHAHRI (Amel)`
A11	`12`	`1`		`@1 ZILI (Jamel)`
A11	`13`	`1`		`@1 MOKHTAR (Insaf)`
A11	`14`	`1`		`@1 MOHAMED RIDHA KAMOUN`
A11	`15`	`1`		`@1 ZAHAF (Abdelmajid)`
A11	`16`	`1`		`@1 CHOSIDOW (Olivier)`
A14	`01`			`@1 La Rabta Hospital, Department of Dermatology @3 TUN @Z 1 aut. @Z 11 aut.`
A14	`02`			`@1 Department of Dermatology, Hôpital Saint Louis, AP-HP @3 FRA @Z 2 aut.`
A14	`03`			`@1 Department of Dermatology, Farhat Hached Hospital @2 Sousse @3 TUN @Z 3 aut. @Z 10 aut.`
A14	`04`			`@1 Military Hospital, Department of Dermatology @3 TUN @Z 4 aut. @Z 9 aut.`
A14	`05`			`@1 Department of Dermatology Hedi Chaker Hospital @2 Sfax @3 TUN @Z 5 aut. @Z 15 aut.`
A14	`06`			`@1 Department of Dermatology Fattouma Bourguiba Hospital @2 Monastir @3 TUN @Z 6 aut. @Z 12 aut.`
A14	`07`			`@1 Habib Thameur Hospital, Department of Dermatology @3 TUN @Z 7 aut. @Z 13 aut.`
A14	`08`			`@1 Charles Nicolle Hospital, Department of Dermatology @3 TUN @Z 8 aut. @Z 14 aut.`
A14	`09`			`@1 Department of Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP @2 Paris @3 FRA @Z 16 aut.`
A20				`@1 108-112`
A21				`@1 2006`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 4530 @5 354000133187210040`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 16 ref.`
A47	`01`	`1`		`@0 06-0128490`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Dermatology : (Basel)`
A66	`01`			`@0 CHE`
C01	`01`		`ENG`	@0 Background: Risk factors for erysipelas (cellulitis) were rarely evaluated in controlled studies. Regional variations of these risk factors have never be assessed. Objective: To assess risk factors for erysipelas of the leg in Tunisia. Subjects and Methods: Case-control study in seven hospital centers in Tunisia. Cases were 114 consecutive patients with erysipelas of the leg [sudden onset (<24 h) of a well-demarcated dermo-hypodermatitis with fever or chills]. Two controls were matched to each case for age, sex, and hospital (n = 208). Main outcome measures are local and general suspected risk factors for erysipelas of the leg. Results: In multivariate analysis, disruption of the cutaneous barrier (i.e. traumatic wound, toe-web intertrigo, excoriated leg dermatosis or plantar squamous lesions) and leg edema were independently associated with erysipelas of the leg, with respective odds ratios of 13.6 (95% confidence interval: 6.0-31) and 7.0 (1.3-38). No association was observed with diabetes, alcoholism, or smoking. Conclusions: We confirmed the major role of local risk factors and the minor role of general risk factors for erysipelas of the leg, in a setting different than the one previously studied. Detecting and treating toe-web intertrigo and traumatic wounds should be considered in the prevention of erysipelas of the leg.
C02	`01`	`X`		`@0 002B08J`
C02	`02`	`X`		`@0 002B05B02C`
C02	`03`	`X`		`@0 002B12B04`
C03	`01`	`X`	`FRE`	`@0 Cellulite @5 01`
C03	`01`	`X`	`ENG`	`@0 Cellulitis @5 01`
C03	`01`	`X`	`SPA`	`@0 Celulitis @5 01`
C03	`02`	`X`	`FRE`	`@0 Lymphoedème @5 02`
C03	`02`	`X`	`ENG`	`@0 Lymphedema @5 02`
C03	`02`	`X`	`SPA`	`@0 Linfedema @5 02`
C03	`03`	`X`	`FRE`	`@0 Intertrigo @5 03`
C03	`03`	`X`	`ENG`	`@0 Intertrigo @5 03`
C03	`03`	`X`	`SPA`	`@0 Intertrigo @5 03`
C03	`04`	`X`	`FRE`	`@0 Facteur risque @5 09`
C03	`04`	`X`	`ENG`	`@0 Risk factor @5 09`
C03	`04`	`X`	`SPA`	`@0 Factor riesgo @5 09`
C03	`05`	`X`	`FRE`	`@0 Erysipèle @5 10`
C03	`05`	`X`	`ENG`	`@0 Erysipelas @5 10`
C03	`05`	`X`	`SPA`	`@0 Erisipela @5 10`
C03	`06`	`X`	`FRE`	`@0 Jambe @5 11`
C03	`06`	`X`	`ENG`	`@0 Leg @5 11`
C03	`06`	`X`	`SPA`	`@0 Pierna @5 11`
C03	`07`	`X`	`FRE`	`@0 Tunisie @2 NG @5 12`
C03	`07`	`X`	`ENG`	`@0 Tunisia @2 NG @5 12`
C03	`07`	`X`	`SPA`	`@0 Tunez @2 NG @5 12`
C03	`08`	`X`	`FRE`	`@0 Etude multicentrique @5 13`
C03	`08`	`X`	`ENG`	`@0 Multicenter study @5 13`
C03	`08`	`X`	`SPA`	`@0 Estudio multicéntrico @5 13`
C03	`09`	`X`	`FRE`	`@0 Etude cas témoin @5 14`
C03	`09`	`X`	`ENG`	`@0 Case control study @5 14`
C03	`09`	`X`	`SPA`	`@0 Estudio caso control @5 14`
C03	`10`	`X`	`FRE`	`@0 Epidémiologie @5 15`
C03	`10`	`X`	`ENG`	`@0 Epidemiology @5 15`
C03	`10`	`X`	`SPA`	`@0 Epidemiología @5 15`
C03	`11`	`X`	`FRE`	`@0 Dermatologie @5 16`
C03	`11`	`X`	`ENG`	`@0 Dermatology @5 16`
C03	`11`	`X`	`SPA`	`@0 Dermatología @5 16`
C03	`12`	`X`	`FRE`	`@0 Homme @5 17`
C03	`12`	`X`	`ENG`	`@0 Human @5 17`
C03	`12`	`X`	`SPA`	`@0 Hombre @5 17`
C03	`13`	`X`	`FRE`	`@0 Médecine tropicale @5 18`
C03	`13`	`X`	`ENG`	`@0 Tropical medicine @5 18`
C03	`13`	`X`	`SPA`	`@0 Medicina tropical @5 18`
C07	`01`	`X`	`FRE`	`@0 Streptococcie`
C07	`01`	`X`	`ENG`	`@0 Streptococcal infection`
C07	`01`	`X`	`SPA`	`@0 Estreptococia`
C07	`02`	`X`	`FRE`	`@0 Bactériose`
C07	`02`	`X`	`ENG`	`@0 Bacteriosis`
C07	`02`	`X`	`SPA`	`@0 Bacteriosis`
C07	`03`	`X`	`FRE`	`@0 Infection`
C07	`03`	`X`	`ENG`	`@0 Infection`
C07	`03`	`X`	`SPA`	`@0 Infección`
C07	`04`	`X`	`FRE`	`@0 Afrique @2 NG`
C07	`04`	`X`	`ENG`	`@0 Africa @2 NG`
C07	`04`	`X`	`SPA`	`@0 Africa @2 NG`
C07	`05`	`X`	`FRE`	`@0 Peau pathologie @5 37`
C07	`05`	`X`	`ENG`	`@0 Skin disease @5 37`
C07	`05`	`X`	`SPA`	`@0 Piel patología @5 37`
C07	`06`	`X`	`FRE`	`@0 Tissu adipeux pathologie @5 38`
C07	`06`	`X`	`ENG`	`@0 Adipose tissue disorders @5 38`
C07	`06`	`X`	`SPA`	`@0 Tejido adiposo patología @5 38`
C07	`07`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 39`
C07	`07`	`X`	`ENG`	`@0 Cardiovascular disease @5 39`
C07	`07`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 39`
C07	`08`	`X`	`FRE`	`@0 Lymphatique pathologie @5 40`
C07	`08`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 40`
C07	`08`	`X`	`SPA`	`@0 Linfático patología @5 40`
N21				`@1 079`

Format Inist (serveur)

NO :	PASCAL 06-0128490 INIST
ET :	Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study
AU :	MOKNI (Mourad); DUPUY (Alain); DENGUEZLI (Mohamed); DHAOUI (Raouf); BOUASSIDA (Samir); AMRI (Montacer); FENNICHE (Sami); ZEGLAOUI (Faten); DOSS (Nejib); NOUIRA (Rafiaa); BEN OSMAN-DHAHRI (Amel); ZILI (Jamel); MOKHTAR (Insaf); MOHAMED RIDHA KAMOUN; ZAHAF (Abdelmajid); CHOSIDOW (Olivier)
AF :	La Rabta Hospital, Department of Dermatology/Tunisie (1 aut., 11 aut.); Department of Dermatology, Hôpital Saint Louis, AP-HP/France (2 aut.); Department of Dermatology, Farhat Hached Hospital/Sousse/Tunisie (3 aut., 10 aut.); Military Hospital, Department of Dermatology/Tunisie (4 aut., 9 aut.); Department of Dermatology Hedi Chaker Hospital/Sfax/Tunisie (5 aut., 15 aut.); Department of Dermatology Fattouma Bourguiba Hospital/Monastir/Tunisie (6 aut., 12 aut.); Habib Thameur Hospital, Department of Dermatology/Tunisie (7 aut., 13 aut.); Charles Nicolle Hospital, Department of Dermatology/Tunisie (8 aut., 14 aut.); Department of Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP/Paris/France (16 aut.)
DT :	Publication en série; Niveau analytique
SO :	Dermatology : (Basel); ISSN 1018-8665; Suisse; Da. 2006; Vol. 212; No. 2; Pp. 108-112; Bibl. 16 ref.
LA :	Anglais
EA :	Background: Risk factors for erysipelas (cellulitis) were rarely evaluated in controlled studies. Regional variations of these risk factors have never be assessed. Objective: To assess risk factors for erysipelas of the leg in Tunisia. Subjects and Methods: Case-control study in seven hospital centers in Tunisia. Cases were 114 consecutive patients with erysipelas of the leg [sudden onset (<24 h) of a well-demarcated dermo-hypodermatitis with fever or chills]. Two controls were matched to each case for age, sex, and hospital (n = 208). Main outcome measures are local and general suspected risk factors for erysipelas of the leg. Results: In multivariate analysis, disruption of the cutaneous barrier (i.e. traumatic wound, toe-web intertrigo, excoriated leg dermatosis or plantar squamous lesions) and leg edema were independently associated with erysipelas of the leg, with respective odds ratios of 13.6 (95% confidence interval: 6.0-31) and 7.0 (1.3-38). No association was observed with diabetes, alcoholism, or smoking. Conclusions: We confirmed the major role of local risk factors and the minor role of general risk factors for erysipelas of the leg, in a setting different than the one previously studied. Detecting and treating toe-web intertrigo and traumatic wounds should be considered in the prevention of erysipelas of the leg.
CC :	002B08J; 002B05B02C; 002B12B04
FD :	Cellulite; Lymphoedème; Intertrigo; Facteur risque; Erysipèle; Jambe; Tunisie; Etude multicentrique; Etude cas témoin; Epidémiologie; Dermatologie; Homme; Médecine tropicale
FG :	Streptococcie; Bactériose; Infection; Afrique; Peau pathologie; Tissu adipeux pathologie; Appareil circulatoire pathologie; Lymphatique pathologie
ED :	Cellulitis; Lymphedema; Intertrigo; Risk factor; Erysipelas; Leg; Tunisia; Multicenter study; Case control study; Epidemiology; Dermatology; Human; Tropical medicine
EG :	Streptococcal infection; Bacteriosis; Infection; Africa; Skin disease; Adipose tissue disorders; Cardiovascular disease; Lymphatic vessel disease
SD :	Celulitis; Linfedema; Intertrigo; Factor riesgo; Erisipela; Pierna; Tunez; Estudio multicéntrico; Estudio caso control; Epidemiología; Dermatología; Hombre; Medicina tropical
LO :	INIST-4530.354000133187210040
ID :	06-0128490

Links to Exploration step

Pascal:06-0128490

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study</title>
<author><name sortKey="Mokni, Mourad" sort="Mokni, Mourad" uniqKey="Mokni M" first="Mourad" last="Mokni">Mourad Mokni</name>
<affiliation><inist:fA14 i1="01"><s1>La Rabta Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dupuy, Alain" sort="Dupuy, Alain" uniqKey="Dupuy A" first="Alain" last="Dupuy">Alain Dupuy</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Dermatology, Hôpital Saint Louis, AP-HP</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Denguezli, Mohamed" sort="Denguezli, Mohamed" uniqKey="Denguezli M" first="Mohamed" last="Denguezli">Mohamed Denguezli</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Dermatology, Farhat Hached Hospital</s1>
<s2>Sousse</s2>
<s3>TUN</s3>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dhaoui, Raouf" sort="Dhaoui, Raouf" uniqKey="Dhaoui R" first="Raouf" last="Dhaoui">Raouf Dhaoui</name>
<affiliation><inist:fA14 i1="04"><s1>Military Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bouassida, Samir" sort="Bouassida, Samir" uniqKey="Bouassida S" first="Samir" last="Bouassida">Samir Bouassida</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Dermatology Hedi Chaker Hospital</s1>
<s2>Sfax</s2>
<s3>TUN</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Amri, Montacer" sort="Amri, Montacer" uniqKey="Amri M" first="Montacer" last="Amri">Montacer Amri</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Dermatology Fattouma Bourguiba Hospital</s1>
<s2>Monastir</s2>
<s3>TUN</s3>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fenniche, Sami" sort="Fenniche, Sami" uniqKey="Fenniche S" first="Sami" last="Fenniche">Sami Fenniche</name>
<affiliation><inist:fA14 i1="07"><s1>Habib Thameur Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>7 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zeglaoui, Faten" sort="Zeglaoui, Faten" uniqKey="Zeglaoui F" first="Faten" last="Zeglaoui">Faten Zeglaoui</name>
<affiliation><inist:fA14 i1="08"><s1>Charles Nicolle Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>8 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Doss, Nejib" sort="Doss, Nejib" uniqKey="Doss N" first="Nejib" last="Doss">Nejib Doss</name>
<affiliation><inist:fA14 i1="04"><s1>Military Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nouira, Rafiaa" sort="Nouira, Rafiaa" uniqKey="Nouira R" first="Rafiaa" last="Nouira">Rafiaa Nouira</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Dermatology, Farhat Hached Hospital</s1>
<s2>Sousse</s2>
<s3>TUN</s3>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ben Osman Dhahri, Amel" sort="Ben Osman Dhahri, Amel" uniqKey="Ben Osman Dhahri A" first="Amel" last="Ben Osman-Dhahri">Amel Ben Osman-Dhahri</name>
<affiliation><inist:fA14 i1="01"><s1>La Rabta Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zili, Jamel" sort="Zili, Jamel" uniqKey="Zili J" first="Jamel" last="Zili">Jamel Zili</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Dermatology Fattouma Bourguiba Hospital</s1>
<s2>Monastir</s2>
<s3>TUN</s3>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mokhtar, Insaf" sort="Mokhtar, Insaf" uniqKey="Mokhtar I" first="Insaf" last="Mokhtar">Insaf Mokhtar</name>
<affiliation><inist:fA14 i1="07"><s1>Habib Thameur Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>7 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mohamed Ridha Kamoun" sort="Mohamed Ridha Kamoun" uniqKey="Mohamed Ridha Kamoun" last="Mohamed Ridha Kamoun">MOHAMED RIDHA KAMOUN</name>
<affiliation><inist:fA14 i1="08"><s1>Charles Nicolle Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>8 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zahaf, Abdelmajid" sort="Zahaf, Abdelmajid" uniqKey="Zahaf A" first="Abdelmajid" last="Zahaf">Abdelmajid Zahaf</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Dermatology Hedi Chaker Hospital</s1>
<s2>Sfax</s2>
<s3>TUN</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chosidow, Olivier" sort="Chosidow, Olivier" uniqKey="Chosidow O" first="Olivier" last="Chosidow">Olivier Chosidow</name>
<affiliation><inist:fA14 i1="09"><s1>Department of Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0128490</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0128490 INIST</idno>
<idno type="RBID">Pascal:06-0128490</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000542</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study</title>
<author><name sortKey="Mokni, Mourad" sort="Mokni, Mourad" uniqKey="Mokni M" first="Mourad" last="Mokni">Mourad Mokni</name>
<affiliation><inist:fA14 i1="01"><s1>La Rabta Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dupuy, Alain" sort="Dupuy, Alain" uniqKey="Dupuy A" first="Alain" last="Dupuy">Alain Dupuy</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Dermatology, Hôpital Saint Louis, AP-HP</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Denguezli, Mohamed" sort="Denguezli, Mohamed" uniqKey="Denguezli M" first="Mohamed" last="Denguezli">Mohamed Denguezli</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Dermatology, Farhat Hached Hospital</s1>
<s2>Sousse</s2>
<s3>TUN</s3>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dhaoui, Raouf" sort="Dhaoui, Raouf" uniqKey="Dhaoui R" first="Raouf" last="Dhaoui">Raouf Dhaoui</name>
<affiliation><inist:fA14 i1="04"><s1>Military Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bouassida, Samir" sort="Bouassida, Samir" uniqKey="Bouassida S" first="Samir" last="Bouassida">Samir Bouassida</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Dermatology Hedi Chaker Hospital</s1>
<s2>Sfax</s2>
<s3>TUN</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Amri, Montacer" sort="Amri, Montacer" uniqKey="Amri M" first="Montacer" last="Amri">Montacer Amri</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Dermatology Fattouma Bourguiba Hospital</s1>
<s2>Monastir</s2>
<s3>TUN</s3>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fenniche, Sami" sort="Fenniche, Sami" uniqKey="Fenniche S" first="Sami" last="Fenniche">Sami Fenniche</name>
<affiliation><inist:fA14 i1="07"><s1>Habib Thameur Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>7 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zeglaoui, Faten" sort="Zeglaoui, Faten" uniqKey="Zeglaoui F" first="Faten" last="Zeglaoui">Faten Zeglaoui</name>
<affiliation><inist:fA14 i1="08"><s1>Charles Nicolle Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>8 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Doss, Nejib" sort="Doss, Nejib" uniqKey="Doss N" first="Nejib" last="Doss">Nejib Doss</name>
<affiliation><inist:fA14 i1="04"><s1>Military Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nouira, Rafiaa" sort="Nouira, Rafiaa" uniqKey="Nouira R" first="Rafiaa" last="Nouira">Rafiaa Nouira</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Dermatology, Farhat Hached Hospital</s1>
<s2>Sousse</s2>
<s3>TUN</s3>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ben Osman Dhahri, Amel" sort="Ben Osman Dhahri, Amel" uniqKey="Ben Osman Dhahri A" first="Amel" last="Ben Osman-Dhahri">Amel Ben Osman-Dhahri</name>
<affiliation><inist:fA14 i1="01"><s1>La Rabta Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zili, Jamel" sort="Zili, Jamel" uniqKey="Zili J" first="Jamel" last="Zili">Jamel Zili</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Dermatology Fattouma Bourguiba Hospital</s1>
<s2>Monastir</s2>
<s3>TUN</s3>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mokhtar, Insaf" sort="Mokhtar, Insaf" uniqKey="Mokhtar I" first="Insaf" last="Mokhtar">Insaf Mokhtar</name>
<affiliation><inist:fA14 i1="07"><s1>Habib Thameur Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>7 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mohamed Ridha Kamoun" sort="Mohamed Ridha Kamoun" uniqKey="Mohamed Ridha Kamoun" last="Mohamed Ridha Kamoun">MOHAMED RIDHA KAMOUN</name>
<affiliation><inist:fA14 i1="08"><s1>Charles Nicolle Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>8 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zahaf, Abdelmajid" sort="Zahaf, Abdelmajid" uniqKey="Zahaf A" first="Abdelmajid" last="Zahaf">Abdelmajid Zahaf</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Dermatology Hedi Chaker Hospital</s1>
<s2>Sfax</s2>
<s3>TUN</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chosidow, Olivier" sort="Chosidow, Olivier" uniqKey="Chosidow O" first="Olivier" last="Chosidow">Olivier Chosidow</name>
<affiliation><inist:fA14 i1="09"><s1>Department of Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Dermatology : (Basel)</title>
<title level="j" type="abbreviated">Dermatology : (Basel)</title>
<idno type="ISSN">1018-8665</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Dermatology : (Basel)</title>
<title level="j" type="abbreviated">Dermatology : (Basel)</title>
<idno type="ISSN">1018-8665</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Case control study</term>
<term>Cellulitis</term>
<term>Dermatology</term>
<term>Epidemiology</term>
<term>Erysipelas</term>
<term>Human</term>
<term>Intertrigo</term>
<term>Leg</term>
<term>Lymphedema</term>
<term>Multicenter study</term>
<term>Risk factor</term>
<term>Tropical medicine</term>
<term>Tunisia</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Cellulite</term>
<term>Lymphoedème</term>
<term>Intertrigo</term>
<term>Facteur risque</term>
<term>Erysipèle</term>
<term>Jambe</term>
<term>Tunisie</term>
<term>Etude multicentrique</term>
<term>Etude cas témoin</term>
<term>Epidémiologie</term>
<term>Dermatologie</term>
<term>Homme</term>
<term>Médecine tropicale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Risk factors for erysipelas (cellulitis) were rarely evaluated in controlled studies. Regional variations of these risk factors have never be assessed. Objective: To assess risk factors for erysipelas of the leg in Tunisia. Subjects and Methods: Case-control study in seven hospital centers in Tunisia. Cases were 114 consecutive patients with erysipelas of the leg [sudden onset (<24 h) of a well-demarcated dermo-hypodermatitis with fever or chills]. Two controls were matched to each case for age, sex, and hospital (n = 208). Main outcome measures are local and general suspected risk factors for erysipelas of the leg. Results: In multivariate analysis, disruption of the cutaneous barrier (i.e. traumatic wound, toe-web intertrigo, excoriated leg dermatosis or plantar squamous lesions) and leg edema were independently associated with erysipelas of the leg, with respective odds ratios of 13.6 (95% confidence interval: 6.0-31) and 7.0 (1.3-38). No association was observed with diabetes, alcoholism, or smoking. Conclusions: We confirmed the major role of local risk factors and the minor role of general risk factors for erysipelas of the leg, in a setting different than the one previously studied. Detecting and treating toe-web intertrigo and traumatic wounds should be considered in the prevention of erysipelas of the leg.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1018-8665</s0>
</fA01>
<fA03 i2="1"><s0>Dermatology : (Basel)</s0>
</fA03>
<fA05><s2>212</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MOKNI (Mourad)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DUPUY (Alain)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>DENGUEZLI (Mohamed)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>DHAOUI (Raouf)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BOUASSIDA (Samir)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>AMRI (Montacer)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>FENNICHE (Sami)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>ZEGLAOUI (Faten)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>DOSS (Nejib)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>NOUIRA (Rafiaa)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>BEN OSMAN-DHAHRI (Amel)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>ZILI (Jamel)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>MOKHTAR (Insaf)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>MOHAMED RIDHA KAMOUN</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>ZAHAF (Abdelmajid)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>CHOSIDOW (Olivier)</s1>
</fA11>
<fA14 i1="01"><s1>La Rabta Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Dermatology, Hôpital Saint Louis, AP-HP</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Dermatology, Farhat Hached Hospital</s1>
<s2>Sousse</s2>
<s3>TUN</s3>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Military Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Dermatology Hedi Chaker Hospital</s1>
<s2>Sfax</s2>
<s3>TUN</s3>
<sZ>5 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Dermatology Fattouma Bourguiba Hospital</s1>
<s2>Monastir</s2>
<s3>TUN</s3>
<sZ>6 aut.</sZ>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Habib Thameur Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>7 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Charles Nicolle Hospital, Department of Dermatology</s1>
<s3>TUN</s3>
<sZ>8 aut.</sZ>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Department of Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA20><s1>108-112</s1>
</fA20>
<fA21><s1>2006</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>4530</s2>
<s5>354000133187210040</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>16 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0128490</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Dermatology : (Basel)</s0>
</fA64>
<fA66 i1="01"><s0>CHE</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background: Risk factors for erysipelas (cellulitis) were rarely evaluated in controlled studies. Regional variations of these risk factors have never be assessed. Objective: To assess risk factors for erysipelas of the leg in Tunisia. Subjects and Methods: Case-control study in seven hospital centers in Tunisia. Cases were 114 consecutive patients with erysipelas of the leg [sudden onset (<24 h) of a well-demarcated dermo-hypodermatitis with fever or chills]. Two controls were matched to each case for age, sex, and hospital (n = 208). Main outcome measures are local and general suspected risk factors for erysipelas of the leg. Results: In multivariate analysis, disruption of the cutaneous barrier (i.e. traumatic wound, toe-web intertrigo, excoriated leg dermatosis or plantar squamous lesions) and leg edema were independently associated with erysipelas of the leg, with respective odds ratios of 13.6 (95% confidence interval: 6.0-31) and 7.0 (1.3-38). No association was observed with diabetes, alcoholism, or smoking. Conclusions: We confirmed the major role of local risk factors and the minor role of general risk factors for erysipelas of the leg, in a setting different than the one previously studied. Detecting and treating toe-web intertrigo and traumatic wounds should be considered in the prevention of erysipelas of the leg.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B08J</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05B02C</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Cellulite</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Cellulitis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Celulitis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Intertrigo</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Intertrigo</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Intertrigo</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Erysipèle</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Erysipelas</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Erisipela</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Jambe</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Leg</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Pierna</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Tunisie</s0>
<s2>NG</s2>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Tunisia</s0>
<s2>NG</s2>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Tunez</s0>
<s2>NG</s2>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Etude multicentrique</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Multicenter study</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Estudio multicéntrico</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Etude cas témoin</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Case control study</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Estudio caso control</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>15</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Dermatologie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Dermatology</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Dermatología</s0>
<s5>16</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Homme</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Human</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Hombre</s0>
<s5>17</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Médecine tropicale</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Tropical medicine</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Medicina tropical</s0>
<s5>18</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Streptococcie</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Streptococcal infection</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Estreptococia</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Bactériose</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Bacteriosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Bacteriosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Afrique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Peau pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Skin disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Piel patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Tissu adipeux pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Adipose tissue disorders</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Tejido adiposo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>079</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 06-0128490 INIST</NO>
<ET>Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study</ET>
<AU>MOKNI (Mourad); DUPUY (Alain); DENGUEZLI (Mohamed); DHAOUI (Raouf); BOUASSIDA (Samir); AMRI (Montacer); FENNICHE (Sami); ZEGLAOUI (Faten); DOSS (Nejib); NOUIRA (Rafiaa); BEN OSMAN-DHAHRI (Amel); ZILI (Jamel); MOKHTAR (Insaf); MOHAMED RIDHA KAMOUN; ZAHAF (Abdelmajid); CHOSIDOW (Olivier)</AU>
<AF>La Rabta Hospital, Department of Dermatology/Tunisie (1 aut., 11 aut.); Department of Dermatology, Hôpital Saint Louis, AP-HP/France (2 aut.); Department of Dermatology, Farhat Hached Hospital/Sousse/Tunisie (3 aut., 10 aut.); Military Hospital, Department of Dermatology/Tunisie (4 aut., 9 aut.); Department of Dermatology Hedi Chaker Hospital/Sfax/Tunisie (5 aut., 15 aut.); Department of Dermatology Fattouma Bourguiba Hospital/Monastir/Tunisie (6 aut., 12 aut.); Habib Thameur Hospital, Department of Dermatology/Tunisie (7 aut., 13 aut.); Charles Nicolle Hospital, Department of Dermatology/Tunisie (8 aut., 14 aut.); Department of Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP/Paris/France (16 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Dermatology : (Basel); ISSN 1018-8665; Suisse; Da. 2006; Vol. 212; No. 2; Pp. 108-112; Bibl. 16 ref.</SO>
<LA>Anglais</LA>
<EA>Background: Risk factors for erysipelas (cellulitis) were rarely evaluated in controlled studies. Regional variations of these risk factors have never be assessed. Objective: To assess risk factors for erysipelas of the leg in Tunisia. Subjects and Methods: Case-control study in seven hospital centers in Tunisia. Cases were 114 consecutive patients with erysipelas of the leg [sudden onset (<24 h) of a well-demarcated dermo-hypodermatitis with fever or chills]. Two controls were matched to each case for age, sex, and hospital (n = 208). Main outcome measures are local and general suspected risk factors for erysipelas of the leg. Results: In multivariate analysis, disruption of the cutaneous barrier (i.e. traumatic wound, toe-web intertrigo, excoriated leg dermatosis or plantar squamous lesions) and leg edema were independently associated with erysipelas of the leg, with respective odds ratios of 13.6 (95% confidence interval: 6.0-31) and 7.0 (1.3-38). No association was observed with diabetes, alcoholism, or smoking. Conclusions: We confirmed the major role of local risk factors and the minor role of general risk factors for erysipelas of the leg, in a setting different than the one previously studied. Detecting and treating toe-web intertrigo and traumatic wounds should be considered in the prevention of erysipelas of the leg.</EA>
<CC>002B08J; 002B05B02C; 002B12B04</CC>
<FD>Cellulite; Lymphoedème; Intertrigo; Facteur risque; Erysipèle; Jambe; Tunisie; Etude multicentrique; Etude cas témoin; Epidémiologie; Dermatologie; Homme; Médecine tropicale</FD>
<FG>Streptococcie; Bactériose; Infection; Afrique; Peau pathologie; Tissu adipeux pathologie; Appareil circulatoire pathologie; Lymphatique pathologie</FG>
<ED>Cellulitis; Lymphedema; Intertrigo; Risk factor; Erysipelas; Leg; Tunisia; Multicenter study; Case control study; Epidemiology; Dermatology; Human; Tropical medicine</ED>
<EG>Streptococcal infection; Bacteriosis; Infection; Africa; Skin disease; Adipose tissue disorders; Cardiovascular disease; Lymphatic vessel disease</EG>
<SD>Celulitis; Linfedema; Intertrigo; Factor riesgo; Erisipela; Pierna; Tunez; Estudio multicéntrico; Estudio caso control; Epidemiología; Dermatología; Hombre; Medicina tropical</SD>
<LO>INIST-4530.354000133187210040</LO>
<ID>06-0128490</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000542 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000542 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:06-0128490
   |texte=   Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study

Risk factors for erysipelas of the leg in Tunisia : A multicenter case-control study

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri